Steven Goldman
Corporate Officer/Principal bei SANA BIOTECHNOLOGY, INC.
Profil
Steven Goldman is the founder of Q Therapeutics, Inc. (founded in 2002).
He is currently the Co-Director at the Center For Translational Neuromedicine (since 2007), a Professor-Neuroscience at the University of Copenhagen (since 2014), a Professor at the University of Rochester Medical Center (since 2003), and the Senior Vice President & Head-CNS Therapy at Sana Biotechnology, Inc. (since 2020).
Previously, he held positions as the Chairman-Neurology Nathan Cummings at Cornell University, the Dean-Biology of the Aging Brain at Rochester Christian University, and a Professor-Neurology at Weill Cornell Medicine (1988-2003).
Dr. Goldman's education includes an undergraduate degree from the University of Pennsylvania, a doctorate from Cornell University, and a doctorate from The Rockefeller University.
Aktive Positionen von Steven Goldman
| Unternehmen | Position | Beginn |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01.10.2020 |
University of Rochester Medical Center
 University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | Corporate Officer/Principal | 01.09.2003 |
Center For Translational Neuromedicine
 Center For Translational Neuromedicine Other Consumer ServicesConsumer Services Part of Rochester Christian University, Center For Translational Neuromedicine is an American company that functions as a College/University. The private company is based in New York. | Corporate Officer/Principal | 01.07.2007 |
| University of Copenhagen | Corporate Officer/Principal | 01.03.2014 |
Ehemalige bekannte Positionen von Steven Goldman
| Unternehmen | Position | Ende |
|---|---|---|
| Weill Cornell Medicine | Corporate Officer/Principal | 01.08.2003 |
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Founder | - |
| Rochester Christian University | Corporate Officer/Principal | - |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - |
Ausbildung von Steven Goldman
| University of Pennsylvania | Undergraduate Degree |
| Cornell University | Doctorate Degree |
| The Rockefeller University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
Center For Translational Neuromedicine
Center For Translational Neuromedicine Other Consumer ServicesConsumer Services Part of Rochester Christian University, Center For Translational Neuromedicine is an American company that functions as a College/University. The private company is based in New York. | Consumer Services |
